Contact lenses

``Our solid first-quarter results demonstrate the strength of our broadly based businesses, especially the strong performance of our pharmaceutical business,'' William Weldon, chairman and chief executive officer of the company, said in the statement.

In the first quarter of 2006, earnings excluding a breakup fee from J&J's failed effort to buy Guidant Corp.

were $3 billion, or 99 cents a share.

To contact the reporter on this story: Lisa Rapaport in New York at Lrapaport1@bloomberg.net Last Updated: April 17, 2007 10:28 EDT Email this articlePrinter friendly format More News U.S.

Consumer Prices Rise 0.6 Percent; Core Rate Climbs Less Than Forecast Stocks in U.S.

Advance on Inflation, Housing Reports; Shares of J&J Gain Dollar Approaches Record Low Against Euro on Concern U.S.

Economy Slowing NEWS 日本語サイト ...

Read more...